4,5-二苯基-2-噁唑丙酸; 贝美格; 恶丙嗪; 3-(4,5-二苯基-1,3-恶唑-2-基)丙酸; 奥沙普嗪; 4,5-二苯基-2-恶唑丙酸; 噁丙嗪; 4,5-二苯-2-【口+咢】唑丙酸; 4,5-二苯基-2-唑丙酸
Oxapro; MFCD00215977; OXAPROSIN; Daypro; 4,5-Diphenyl-2-oxazolepropanoic acid Daypro; Oxaprozin; 4,5-Diphenyl-2-oxazolepropanoic acid,Daypro; 4,5-Diphenyl-2-oxazolepropionic Acid; Duraprost; 3-(4,5-Diphenyloxazol-2-yl)propanoic acid; Durapro; Dxaprozin; 2-Oxazolepropanoic acid, 4,5-diphenyl-; 3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoic acid; 4,5-diphenyloxazole-2-propanoic acid; Actirin; Alvo; EINECS 244-296-1; OXAPROZINE; DAYPRO; 4,5-DIPHENYL-2-OXAZOLEPROPANOIC ACID; 3-(4,5-DIPHENYL-1,3-OXAZOL-2-YL)PROPANOIC ACID; 3-(4,5-DIPHENYL-1,3-OXAZOL-2-YL)PROPIONIC ACID; 3-(4,5-DIPHENYL-2-OXAZOLYL)PROPIONIC ACID
室温,密封
水溶性:不溶;可溶于:甲醇;极微溶:乙醚
1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:1 3.氢键受体数量:4 4.可旋转化学键数量:5 5.互变异构体数量:2 6.拓扑分子极性表面积:63.3 7.重原子数量:22 8.表面电荷:0 9.复杂度:361 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1